Swiss pharmaceuticals giant Novartis said Tuesday that group sales exceeded expectations in the second quarter of 2026, on the back of a range of new products.
Novartis said in a statement that sales in the period from April to June rose by three percent to $14.4 billion (12.6 billion euros), compared with the second quarter of 2025.
That was slightly higher than the $14 billion forecast by analysts polled by Swiss agency AWP.
The Basel-based group is facing the expiry of patents for a number of its drugs, including Entresto, a flagship treatment for heart failure.
In 2025, Entresto alone generated annual sales of $7.7 billion, even though its sales had already fallen sharply in the fourth quarter after its patent expired in the United States in July of that year.
Rhapsido, a treatment for chronic rashes that was approved in the US last September and then in the European Union at the end of April, has already generated $64 million in sales, Novartis said.
Net profit fell by 19 percent to $3.2 billion, hit by higher interest and tax expenses, the group explained.
Novartis confirmed its targets for 2026 and said it is still aiming for "low single-digit" sales growth for the whole year.
Latest stories
France Menacé par la DZ Mafia, le maire d'Alès exfiltré de son domicile
D'abord deux balles de 9mm et des tags à son domicile, puis une exfiltration en pleine nuit : le maire LR d'Alès Christophe Rivenq est la cible de menaces attribuées au groupe criminel DZ Mafia qui a...
France SNCF : Jean Castex annonce le départ du PDG de SNCF Voyageurs et réorganise cette filiale
Le patron de la SNCF Jean Castex a annoncé mardi une réorganisation de la gouvernance de la filiale SNCF Voyageurs, dont l'actuel PDG Christophe Fanichet, architecte de l'ouverture à la concurrence, va être remplacé par deux personnes...
La Une En Afghanistan, la pluie complique les recherches des disparus d'une crue dévastatrice
De nouvelles pluies compliquent mardi les recherches des corps d'une centaine de personnes toujours portées disparues dans les crues meurtrières qui ont frappé la veille une...